technetium tc 99m sestamibi has been researched along with Paraproteinemias in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beksac, M; Comenzo, RL; Dimopoulos, M; Durie, BG; Kumar, S; Lokhorst, H; Moulopoulos, LA; Niesvizky, R; Rajkumar, SV; Sezer, O; Siegel, D; Terpos, E; Tosi, P | 1 |
| Bacovsky, J; Buriankova, E; Koranda, P; Minarik, J; Myslivecek, M; Pika, T; Scudla, V; Zapletalova, J | 1 |
| Bartel, T; Brown, TL; De Blanche, L; Jones-Jackson, LB; Walker, RC | 1 |
| Bacovsky, J; Myslivecek, M; Nekula, J; Scudla, V; Vytrasová, M | 1 |
| Alba, PR; Banzo, JB; Dourdil Sahún, MV; Martín, MG; Olave, P; Romero Colás, MS | 1 |
| Cavalli, F; Ceriani, L; Delaloye, AB; Giovanella, L; Taborelli, M; Zucca, E | 1 |
| Agnese, G; Balleari, E; Carletto, M; Clavio, M; Ferrando, F; Garrè, S; Ghio, R; Ghirlanda, P; Gobbi, M; Mariani, G; Villa, G | 1 |
2 review(s) available for technetium tc 99m sestamibi and Paraproteinemias
| Article | Year |
|---|---|
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Topics: Absorptiometry, Photon; Bone Neoplasms; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Prognosis; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2009 |
Imaging of multiple myeloma and related plasma cell dyscrasias.
Topics: Bone and Bones; Bone Marrow Neoplasms; Bone Neoplasms; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Paraproteinemias; POEMS Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
2 trial(s) available for technetium tc 99m sestamibi and Paraproteinemias
| Article | Year |
|---|---|
Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Prognosis; Radionuclide Imaging; Survival Analysis; Technetium Tc 99m Sestamibi | 2010 |
Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease Progression; Female; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
3 other study(ies) available for technetium tc 99m sestamibi and Paraproteinemias
| Article | Year |
|---|---|
BaselinTc99-MIBI scanning predicts survival in multiple myeloma and helps to differentiate this disease from monoclonal gammopathy of unknown significance.
Topics: Diagnosis, Differential; Humans; Multiple Myeloma; Paraproteinemias; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi | 2005 |
99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
Topics: Bone Marrow; Female; Humans; Karyotyping; Male; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2008 |
Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2001 |